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Abstract 
Tendon is a dense connective tissue that transmits 
high mechanical forces from skeletal muscle to 
bone. The transcription factor scleraxis (Scx) is a 
highly specific marker of both precursor and mature 
tendon cells (tenocytes). Mice lacking scx exhibit a 
specific and virtually complete loss of tendons 
during development. However, the functional 
contribution of Scx to wound healing in adult tendon 
has not yet been fully characterized. Here, using 
ScxGFP-tracking and loss-of-function systems, we 
show in an adult mouse model of Achilles tendon 
injury that paratenon cells, representing a stem cell 
antigen-1 (Sca-1)-positive and Scx-negative 
progenitor subpopulation, display Scx induction, 
migrate to the wound site, and produce extracellular 
matrix (ECM) to bridge the defect, whereas resident 
tenocytes exhibit a delayed response. Scx induction 
in the progenitors is initiated by transforming growth 
factor β (TGF-β)-signaling. Scx-deficient mice had 
migration of Sca-1-positive progenitor cell to the 
lesion site, but impaired ECM assembly to bridge 
the defect. Mechanistically, scx-null progenitors 
displayed higher chondrogenic potential with up-
regulation of SRY-box 9 (Sox9) coactivator PPAR-
gamma coactivator 1α (PGC-1α) in vitro, and knock-
in analysis revealed that forced-expression of full-
length scx significantly inhibited sox9 expression. 
Accordingly, scx-null wounds formed cartilage-like 
tissues that developed ectopic ossification. Our 
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findings indicate a critical role of Scx in a 
progenitor-cell-lineage in wound healing of adult 
mouse tendon. These progenitor cells could 
represent targets in strategies to facilitate tendon 
repair. We propose that this lineage-regulatory 
mechanism in tissue progenitors could apply to a 
broader set of tissues or biological systems in the 
body. 
 
 
 
Introduction 
 
Tendon is a dense connective tissue rich in 
extracellular matrix (ECM) and it transmits high 
contraction forces from skeletal muscle to bone, 
thanks to dense, robust and highly organized parallel 
and longitudinal collagen bundles (1-3). Resident 
tendon cells, ‘tenocytes’, like skeletal myoblasts, 
chondrocytes, and osteoblasts, originate during 
embryogenesis from multipotent mesenchymal cells 
and actively produce unique and tendon-specific 
ECM (4). Adult tendon injury, overuse and age-
related degeneration is a difficult clinical problem 
that occurs frequently. Injured tendon heals very 
slowly and is rarely restored to its normal 
undamaged state in terms of its structural integrity. 
The reasons behind of the slow healing response to 
injury and the exact nature of the cells responsible 
for the complex repair process are still poorly 
understood (5-7).  
    Scleraxis (Scx), a basic helix-loop-helix (bHLH) 
transcription factor, was recently identified as a 
highly specific marker of tenogenic precursor cells 
and mature differentiated tenocytes during 
development (8,9). Mice lacking the scx gene are 
viable but show a specific and virtually complete 
loss of major force-transmitting and intermuscular 
tendons (10). Scx is thus the master gene shown to 
be crucial for the tendon lineage. The examination of 
changes in Scx expression offers an ideal tool for 
analyzing alterations in adult tendon tissue 
remodeling.  
    We have previously demonstrated that the 
expression of Scx in tenocytes is regulated by 
transforming growth factor-β (TGF-β)/Smad2/3-
mediated signaling (11). Tenocytes in 
tendons/ligaments with osteoarthritis acquire 
chondrogenic potential, e.g., they show 
downregulation of Scx and upregulation of the 
chondrocyte marker Sry-type HMG box 9 (Sox9), 
strongly suggesting that chondrogenic differentiation 
is associated with the progression of degeneration in 
tendons/ligaments (12). Whereas these two 
transcription factors, Scx and Sox9, coordinately 
regulate the determination of cellular lineages during 
embryonic development (13), their precise 
contribution to and signaling pathways involving 
lineage specifications are still largely unknown. 
Furthermore, no comprehensive study to explore the 
functional role of Scx following adult tendon injury 
has yet been carried out. Tendon stem/progenitor 
cells have been shown to exist in adult normal 
human and mouse tendon (14) and they localize in 
both tendon proper (within the endotenon) and 
peritenon (including paratenon and epitenon) (15,16). 
It still remains to be elucidated what cell type plays 
the main role in adult tendon healing/remodeling 
following injury and how Scx regulates these 
tendon-cell phenotypes during these 
processes. Nevertheless, no studies to date identify a 
definitive requirement for Scx in response to adult 
tendon injury.  
    In the present study, we used a combination of 
ScxGFP-tracking and loss-of-function systems to 
explore whether Scx is a suitable molecular target 
for accelerating the healing response to adult tendon 
injury. We have taken advantage of ScxGFP 
transgenic mice, which express the marker green 
fluorescent protein (GFP) driven by scx regulatory 
sequences such that this allows one to track 
tenocytes at any time following adult tendon injury 
using ScxGFP as a marker (9,11). Since complete 
deletion of the scx gene during development results 
in severe tendon-defect phenotypes (10), we have 
utilized adenovirus-Cre to induce deletion of the scx 
gene only in injured adult tendon tissues. Here we 
show a critical role of Scx in adult tendon progenitor 
cell-lineage in the repair following tendon injury.  
 
 
 
Results  
 
Cells in the paratenon are involved in repair 
following adult Achilles tendon injury 
The sudden loss of tensile loading in the complete 
Achilles tendon transection model induces an 
excessive release of active TGF-β and causes 
massive tendon cell death (11). This model is not 
suitable for assessment of the contribution, if any, of 
resident tenocytes to adult tendon wound healing. 
The complete tendon transection model is also 
known to result in chondroid 
degeneration/ossification at the edges in addition to 
regeneration in the center of injured tendons 
following injury (17-20). Therefore, we developed a 
simple and reproducible Achilles tendon ‘partial-
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transection’ model in which tensile loading from 
skeletal muscles is not completely lost (Fig. 1A). To 
track the healing process following tendon injury in 
a dynamic fashion, we studied the tissue distribution 
of tenocytes and the expression levels of Scx using 
ScxGFP as a tenocyte marker. Indeed, a majority of 
resident tenocytes (~94% of total cells were ScxGFP 
positive) in adult Achilles tendons from ScxGFP 
transgenic mice robustly expressed ScxGFP  
(Supplementary Fig. 1) (11).  
    Tendon wound healing involves both regeneration 
of tenocytes and reconstruction of extracellular 
matrices (ECMs), which are mainly composed of 
collagen fibrils. ECM repair is known to proceed 
through three overlapping stages: an initial 
inflammatory stage (typically spanning a few days 
post injury), a proliferative stage (starting a few days 
post injury), and a remodeling stage (starting 
approximately 1-2 months post injury) (for reviews, 
see (5,21)). Since tensile loading is important for the 
maintenance of Scx expression in adult tenocytes 
(11), we have hypothesized that partial transection of 
the Achilles tendon affects its expression of Scx. In 
the inflammatory phase following partial transection, 
a marked decrease in the number of ScxGFP-
positive cells was already observed at 3 hr post 
injury, and terminal deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL)-positive cells 
were detected (Fig. 1B and 1C). This region had 
become virtually acellular by day 2 (~16.0% of 
DAPI-positive cells were ScxGFP positive; Fig. 1C, 
arrowheads). In the proliferative phase, marked 
cellular hyperplasia of the paratenon close to the 
wounded region was observed. Those cells showed a 
continuous cellular stream from paratenon to 
wounded site at 1 week following injury (Fig. 1D, 
HE section), and ~46.7% of those cells (84 of 180 
DAPI-positive cells) were found to express ScxGFP 
(Fig. 1D, ScxGFP/DAPI section). At 2 weeks 
following injury, the majority of those cells (156 of a 
total of 184 DAPI-positive cells; ~84.8%) 
manifested as a series of robustly ScxGFP-
expressing cells in the wound region (Fig. 1D), and 
there was a continuous, intense ScxGFP-positive 
cellular stream from paratenon to wounded site 
(hereafter called “wound ScxGFP cells”) 
(Supplementary Fig. 2). The wound was filled up 
with those cells by 4 weeks (Fig. 1D).  
 
ECM remodeling in adult tendon wound healing 
is different from that in other tissues 
ECM remodeling during tendon wound healing is 
thought to follow the same processes as in other 
tissues. In general, a provisional matrix is initially 
formed with the plasma proteins fibrinogen and 
fibronectin, which triggers fibroblast migration. 
Fibroblasts that have migrated to the wound site play 
a major role in remodeling the ECM, followed by 
replacement of the provisional matrix by collagen 
type III, and then type I fibrils (22,23). Following 
injury by partial transection of the Achilles tendon, 
however, there was little exudation of fibrinogen, 
and little angiogenesis (as judged by the endothelial-
cell marker, platelet endothelial cell adhesion 
molecule (PECAM-1 [CD31])) in the wounded 
region by 1 week due to the largely avascular nature 
of adult tendon ((5), Supplementary Fig. 3). In ECM 
remodeling following injury, collagen type III is 
synthesized as procollagen III in a similar manner to 
collagen type I. However, while most of the N-
propeptide of the procollagen type I molecule is 
cleaved, the type III N-propeptide is processed 
partially (24). We tracked the assembly and cellular 
source of collagen type III using anti type III N-
propeptide antibody. Immunofluorescence analysis 
revealed that the deposition of collagen type III was 
evident in the ECM of wound site, and it formed a 
collagenous bridge over the defect space at 2 weeks 
following injury (Fig. 2A, arrows). Those collagen 
type III fibrils were overlapped with “wound 
ScxGFP cells” in the wounded site (~61.7 % of total 
DAPI-positive cells), suggesting “wound ScxGFP 
cells” as a cellular source in collagen production 
(Fig. 2A). The collagen type III fibrils deposited had 
been gradually replaced by de novo collagen type I 
fibrils by 4 weeks, whereas at 2 weeks very little 
deposition of collagen type I was found at the wound 
site (Fig. 2A and 2B). The deposition of the small 
leucine-rich proteoglycan fibromodulin and cartilage 
oligomeric matrix protein (COMP or 
thrombospondin 5), which play regulatory roles in 
collagen matrix assembly (25,26), was also observed 
at 4 weeks after injury (Fig. 2B). The deposited 
ECMs and cells in the wound site often showed the 
pattern aligned perpendicular to the tendon axis (Fig. 
2). Since Scx is not expressed in non-tendon adult 
fibroblasts (11), these findings suggest that, unlike 
other tissues, “wound ScxGFP cells” could be the 
principal source of cells that reconstruct the 
damaged ECM following tendon injury.  
 
Tendon progenitor cells that reside in the 
paratenon differentiate into ScxGFP-expressing 
tenocytes and contribute as a main player to 
tendon wound healing 
   Next we determined the cellular origin of “wound 
ScxGFP cells”, which are significant players 
following tendon injury. In the adult complete 
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Achilles tendon transection model, extrinsic cells 
have been suggested to play a role in scar formation 
following injury (20). Such cells may derive from i) 
vascular endothelial cells (27); ii) bone-marrow-
derived stromal cells (BMSCs) which have been 
shown to migrate into damaged tissues in response 
to injury or inflammation (28); or iii) in situ tendon 
progenitor cells (14). Immunostaining for the 
endothelial cell marker PECAM showed no 
significant cellular distribution at 2 weeks following 
injury (Fig. 3A). Immunostaining for CD18, a 
surface receptor integrin β2 chain present on BMSCs, 
showed very scattered positive-cell distribution in 
the wounded tendon at 2 weeks (Fig. 3A). Bone-
marrow-transplantation analysis further confirmed 
that the cells that had migrated from bone marrow to 
the tendon wound site comprised less than 15% of 
the total cells (14.9 ± 3.9% at 1 week and 11.2 ± 
3.2% at 2 weeks following injury; Supplementary 
Fig. 4), suggesting that BMSCs did not have a major 
contribution to adult tendon wound healing.  
    Tendon progenitor cells have been shown to exist 
in adult mouse tendons. They express stem cell 
antigen-1 (Sca-1) and CD44, but are negative for 
CD18, a surface receptor integrin β2 chain present 
on BMSCs (14). In a study of the tissue distribution 
of progenitor cells in adult untreated Achilles tendon, 
the progenitor cells were found to localize in the 
paratenon region, showing a characteristic pattern of 
cell-surface markers: Sca-1 positive as a progenitor 
marker, Ki67 negative as a proliferation marker, and 
ScxGFP negative (Fig. 3B). In contrast, a notable 
expansion of Sca-1-positive cells was observed in 
the markedly thickened paratenon region at 2 weeks 
following injury, as evidenced by marked numbers 
of Sca-1 positive cells and some Ki67 positive cells, 
and we identified Sca-1/ScxGFP double positive 
cells in the intra-tendinous region (Fig. 3B). We 
hypothesized that those progenitors contributed as 
major players in tendon wound healing. At 2 weeks 
following injury, there was a continuous Sca-1-
positive cellular stream from paratenon to wound 
site (Fig. 3A), and importantly, ~22.4% of total 
DAPI-positive cells were double-positive for Sca-
1/ScxGFP in the wound site (Fig. 3A). There were 
very few Ki67 positive cells in the intra-tendinous 
region (data not shown). 
    Resident mature tenocytes existing originally in 
tendon tissues (tendon proper) may contribute to 
repair following injury. Indeed, we found those cells 
as a minor population within adjacent tendon struts 
following injury (Supplementary Fig. 2). Those cells 
aligned parallel to the tendon axis with 
rounded/polygonal morphology. They expressed 
tyrosine 397-phosphorylated focal adhesion kinase 
(pFAK-Tyr397) and activated integrin β1, 
suggesting active migration in response to injury 
(Supplementary Fig. 5). However, those cells 
showed a delayed response compared to “wound 
ScxGFP cells”: Unlike wound ScxGFP cells at 1 and 
2 weeks (Fig. 1D, HE at 1 week and ScxGFP at 2 
weeks), those resident tenocytes did not have a 
continuous cellular stream to the wounded site and 
distributed away from the wound with lower 
expression levels of ScxGFP. Taking these findings 
together, we concluded that: i) Sca-1-positive tendon 
progenitor cells localized in the paratenon likely 
migrate to the wound site, differentiate into ScxGFP-
expressing tenocytes, function as the principal cell 
type involved in adult tendon healing and actively 
produce collagen fibrils to repair the damaged 
tendon; and ii) resident Scx-expressing tenocytes are 
also likely to migrate to the wound site but only in 
the later stages after the progenitor cells have made 
their contribution.  
 
Isolation, generation, and characterization of 
mouse adult tendon progenitor cell lines 
Next, to investigate further the role of Scx in tendon 
progenitor cell phenotypes, we generated progenitor 
cell lines from adult scx(flox/flox)/ScxGFP mouse 
Achilles tendon under a Trp53- and Cdkn1a (p21)-
null genetic background (23). Flow cytometry 
analysis to study cell-surface markers showed that 
the progenitor cell lines generated were positive for 
the stem-cell marker stem cell antigen-1 (Sca-1; 
98.9% positivity), CD44 (99.8%), and CD90.2 
(97.3%), very low level for the bone marrow stromal 
cell  marker CD18 (~3%), the endothelial cell 
marker CD31 (~3%), the leukocyte marker CD45 
(~3%), and ScxGFP (2.3%), and low expression for 
the stem cell marker CD34 (6%) (Fig. 4A and data 
not shown) (14).  
    TGF-β is the most potent cytokine to induce 
ScxGFP expression in adult resident tenocytes in 
vitro (11). A recent transcriptomic analysis of mouse 
embryonic limb tendon cells during development has 
shown that TGF-β signaling via Smad2/3 is 
necessary and sufficient to drive mouse mesodermal 
cell differentiation toward the tendon lineage (29). 
Ten candidate molecules had been examined for a 
role in the induction of Scx expression in adult 
tendon progenitors (16,30-34). TGF-β1, -β2, and -β3 
were the most potent and were able to induce 
ScxGFP expression in vitro, although TGF-β2 was 
less potent than TGF-β1 and -β3 (Supplementary Fig. 
6A). However, the expression level of ScxGFP in 
progenitors in response to TGF-β1 was markedly 
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lower (~67.2%; P < 0.01) than in adult tenocytes 
(Supplementary Fig. 6B). Neither the osteo-
inductive cytokine BMP2 (35), used as a negative 
control, nor any other cytokine/growth factor 
examined had any effect (Supplementary Fig. 
6A). In TGF-β signaling, the ligand TGF-β binds to 
cell surface TGF-β receptors. On binding of the 
ligand, receptor complexes initiate downstream 
Smad-signaling pathways (36,37). Indeed, some 
cells in the continuous cellular stream from 
paratenon to wound site at 2 weeks following tendon 
injury were found to express nuclear phospho-
Smad2, and some of them were double-positive for 
pSmad2/ScxGFP (Fig. 3C). These findings suggest 
that cytokine TGF-β could participate in the 
differentiation of adult tendon progenitors into 
ScxGFP-expressing tenocytes during adult tendon 
wound healing.  
 
Scx-null tendon progenitors display significantly 
higher chondrogenic potential in vitro 
The parental progenitor clones established as 
described above were subsequently treated with a 
Cre-transducing adenovirus to delete the scx-floxed 
genes, and scx-null progenitor cell lines were 
generated (Supplementary Fig. 7). We then explored 
whether the loss of the scx gene leads to alteration of 
progenitor cell self-renewal potential by colony-
forming unit (CFU) assay. Interestingly, the scx-null 
progenitor cells formed significantly more colonies 
(~1.56-fold increase) than parental cells at day 10 (P 
< 0.01; Fig. 4B), although Scx was found to be 
negative for parental progenitor cells (Fig. 4A).     
    To investigate further whether the differentiation 
potential of tendon progenitor cells is affected by the 
absence of Scx, cells were subjected to adipogenic, 
chondrogenic, and osteogenic differentiation 
analyses. Indeed, scx-null and its parental progenitor 
cells successfully differentiated into the three 
lineages (Fig. 4C-4E). When progenitor cells were 
transferred to micromass cultures with TGF-β to 
induce chondrogenic differentiation (38), scx-null 
progenitor cells showed significantly higher mRNA 
levels of chondrogenic markers such as Sox9 and 
type II collagen from an early stage (day 7) of 
chondrogenic differentiation (Fig. 4C). At day 21, 
scx-null cell cultures showed cartilage-like tissue 
formations (Fig. 4C). Although the tendon 
progenitor cells from fibromodulin/biglycan double-
null mice exhibit downregulation of scx expression 
(14), scx-null progenitors did not show significant 
alteration of fibromodulin or biglycan mRNA levels 
compared to parental controls when stimulated to 
differentiate toward chondrogenic lineage (data not 
shown). In adipogenesis, the accumulation of 
intracellular lipids is used as a marker of adipocyte 
differentiation (39): scx-null cultures developed 
adipocytes that contained significantly larger lipid 
droplets, as evidenced by Oil Red O staining. The 
number of adipocytes that contained lipid droplets 
more than 35 µm in diameter was 16.0 ± 3.6 
cells/field in scx-null cultures versus 6.5 ± 1.3 
cells/field in parental cultures [n = 4; field = 0.25 
mm2; P < 0.01]; Fig. 4D).  In osteogenesis, the 
production of mineralized and amorphous substances 
was increased in scx-null cells compared to control 
parental cells, as evidenced by Alizarin Red staining, 
although the areas of mineralized matrix formed did 
not show a significant difference statistically (8.00 ± 
1.8% in scx-null cultures versus 7.23 ± 0.4% in 
parental cultures [n = 4; field = 1.6 mm2; P = 0.45]; 
Fig. 4E). Furthermore, the expression levels of 
phoshpo-Smad1/5/8 (pSmad1/5/8) protein and runt-
related gene 2 (runx2) mRNA in the presence of the 
osteogenesis inducer BMP2 (14,40) were similar 
between scx-null and parental cell cultures 
(Supplementary Fig. 8). Taken together, these 
findings indicate that the loss of Scx results in 
enhanced differentiation potential of tendon 
progenitor cells.  
 
The absence of Scx results in a defect in 
progenitor differentiation into Scx-expressing 
tenocytes and tendon repair  
To further explore the functional role of Scx in adult 
tendon wound healing, we developed here an 
Achilles tendon-specific scx-conditional knockout 
model in adult mice. Although we found that Scx-
GFP-expressing tenocytes originating from tendon 
progenitor cells played a significant role in the early 
stages (at least for up to 28 days) following Achilles 
tendon injury (Fig. 1, Supplementary Fig. 2), we 
could not exclude the possibility that resident 
tenocytes expressing Scx participate in the healing 
process at certain time points, e.g., a later 
remodeling stage. To circumvent this, we utilized a 
scx-floxed mouse strain, and an adenovirus encoding 
Cre recombinase was injected locally into wounded 
tendons to inactivate the scx gene. To study the 
efficiency of adenovirus encoding Cre recombinase 
in the deletion of the target gene, we performed 
initial studies using mice harboring the well-
characterized Rosa26 floxed-LacZ gene. This gene 
expresses a bifunctional lacZ/neomycin 
phosphotransferase protein in any cell (and cell 
progeny) once recombined by Cre (41). We found 
that a single injection of adenovirus-Cre (1 x 109 
multiplicity of infection [MOI] in 10 μL PBS) into 
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the Achilles tendon of Rosa26 mice showed efficient 
gene recombination in tenocytes at 1 week after 
injection (Supplementary Fig. 9A).  No endogenous 
LacZ expression was found in the Achilles tendon of 
wild-type mice (data not shown). We also gave a 
single injection of 1 x 109 MOI adenovirus-Cre into 
the Achilles tendon of adult scx(flox/flox) mice and 
confirmed considerably decreased expression of Scx 
protein in tenocytes by immunohistochemistry at 1 
week after injection (Supplementary Fig. 9B), 
confirming that this model resulted in the efficient 
deletion of floxed alleles in the scx gene. No 
decrease in tenocyte numbers was observed when 
adenovirus-GFP was injected as a control (data not 
shown). Thus, we established an adult mouse model 
in which inactivation of the scx gene was induced 
locally and specifically in all cells from Achilles 
tendons. 
        Next, to delete the scx gene at the time of 
tendon injury in adult scx(flox/flox)/ScxGFP 
transgene mice, we pretreated Achilles tendons with 
adenovirus-Cre at 1 x 109 MOI for 20  min (scx-
Achilles KO mice), and then partially transected the 
Achilles tendons. The wounds in adenovirus-Cre-
untreated control mice were filled with ScxGFP-
expressing tendon cells and built up with de novo 
collagen type I fibrils by day 28 (Fig. 2B). In 
contrast, although the wounds in scx-Achilles KO 
mice showed migration of paratenon-derived Sca-1-
positive progenitors to the wound site at 4 weeks 
after injury, those cells failed to undergo 
downregulation of Sca-1 and induction of ScxGFP 
during migration from paratenon to the wound site 
and still retained high expression levels of Sca-1 
(Fig. 5A). Moreover, the cells that had migrated to 
the wound site showed abnormal deposition patterns 
of ECMs at 4 weeks after injury (Fig. 5B). In the 
control wound, the deposited collagen type III in the 
wounded site was gradually replaced with type I 
collagen fibrils from 2 to 4 weeks following injury 
(Fig. 2). In contrast, in mutant wounds, the deposited 
collagen type III was not replaced with collagen type 
I by 4 weeks (Fig. 5B). Interestingly, the mutant 
wound also lacked deposition of the small leucine-
rich proteoglycan fibromodulin and COMP at 4 
weeks (Figs. 5B and 2B).  
    Subsequent histopathological analyses revealed 
the Alcian blue-positive foci composed of 
chondrocyte-like cells in mutant wounds from 4 
weeks following injury (Fig. 6A). Such foci were 
observed in all mutant wounds (6 out of 6), whereas 
no foci were found in control wounds. Since scx-null 
tendon progenitors displayed significantly higher 
chondrogenic potential in vitro (Fig. 4C), we 
hypothesized that tendon progenitor derivatives 
lacking Scx had indeed undergone a fate change and 
possessed chondrogenic potential in vivo. As 
expected, ECMs in the mutant wounded site were 
composed of the cartilage markers collagen type II 
and aggrecan (Fig. 6B). It is known that ectopic 
mineralization can be caused by the endochondral 
ossification program (42). Consistent with these 
interpretations, in longer-term follow up, such foci 
demonstrated ectopic ossification from 8 weeks and 
were surrounded by chondrocyte-like cells (Fig. 6C). 
Micro computed tomography (micro-CT) analysis 
clearly showed ectopic ossification foci in the 
mutant wound at 15 weeks following injury (Fig. 
6D), indicating that the absence of Scx causes the 
phenotypes of tendon progenitors to switch to a 
genuine chondrocyte cell fate in vivo. Neither 
cartilage nor ectopic ossification foci were formed in 
partial transection wounds in control mice. No 
significant phenotypic differences were observed 
between mice that had received no adenovirus and 
those that had received the control adenovirus (data 
not shown), ruling out any major cytotoxic effect of 
the viral solution itself. PBS-injected and sham-
operated Achilles tendons did not show any disease 
phenotype (data not shown).  
    Next, the functional link between Scx and Sox9-
mediated chondrogenesis was further addressed in 
vitro. There is evidence that peroxisome proliferator-
activated receptor (PPAR) γ coactivator 1α (PGC-
1α) acts as a coactivator for Sox9 to regulate 
cartilage-specific transcriptional activities during 
chondrogenesis. Furthermore, PGC-1α regulates 
Sox9-dependent chondrogenesis in mesenchymal 
stem cells (MSCs) and chondrocytes in vitro (43). 
We therefore compared the expression levels of 
PGC-1α between parental and scx-null progenitor 
cells during chondrogenic differentiation. At 24 hr 
after the induction of chondrogenic differentiation, 
scx-null progenitor cells showed marked up-
regulation (~4.0-fold increase) of PGC-1α protein 
compared to parental cells (Fig. 6E).     
    Finally, to investigate the direct involvement of 
Scx (the structural requirement for Scx) in the 
negative regulation of chondrogenesis, we 
performed rescue experiments by knock-in of full-
length scx and mutated scx genes into scx-null 
tenocytes. We recently established scx-null tenocyte 
lines and tenocyte lines overexpressing full-length 
Scx (scx-full) N-terminal Flag-tag fusion protein 
(12). In this study, we generated tenocyte lines 
overexpressing basic DNA-binding domain-deleted 
Scx (scx∆Base) and Flag-tag fusion protein and 
tenocyte lines overexpressing helix-loop-helix 
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protein interaction domain-deleted Scx (scx∆HLH) 
and Flag-tag fusion protein (Supplementary Fig. 10). 
These tenocyte clones were induced to undergo 
chondrogenic differentiation in vitro for 5 days and 
their expression levels of Sox9 mRNA were 
compared. The absence of the scx gene (scx-null) 
resulted in significant upregulation (~1.6-fold 
increase; P < 0.05) of Sox9 compared to 
scx(flox/flox) tenocytes that express Scx at 
physiological levels. Cells overexpressing Scx∆Base 
also showed significant upregulation (~1.4-fold 
increase; P < 0.05) of Sox9 compared to 
scx(flox/flox) tenocytes. Cells overexpressing 
Scx∆HLH showed a slight though not significant 
upregulation of Sox9. In sharp contrast, cells 
overexpressing full-length Scx showed significant 
downregulation (~2.6-fold decrease; P < 0.05) of 
Sox9 compared to scx(flox/flox) tenocytes. Thus, 
taken together, these findings indicate that the 
promotion and maintenance of increased Scx 
expression levels could be essential elements to 
decrease the chondrogenic potential and to improve 
the slow-healing response to adult tendon injury. 
 
 
 
Discussion 
 
We have investigated in the present study whether 
Scx is a suitable molecular target for accelerating the 
healing response to adult tendon injury. Our 
comprehensive studies of adult tendon wound 
healing with ScxGFP transgenic and conditional scx-
deficient animal models provide compelling 
evidence for the following propositions: 1) Scx plays 
indispensable roles in proper healing following adult 
tendon injury; 2) There is a direct link between 
tendon progenitor cell-lineage mediated by Scx and 
adult tendon pathology; and 3) Certain Sca-1-
positive progenitor subpopulations identified in the 
paratenon could provide novel targets to develop 
strategies to facilitate tendon repair. We propose that 
the regulatory mechanisms underlying lineage-
specific differentiation in adult tissue progenitors 
mediated by transcription factor Scx shown here 
could translate into regenerative therapy for a 
broader variety of tissues or systems in the body.   
    Although adult tendon wound healing has been 
suggested to follow the same process as other 
organs/tissues (for reviews, see (5,21)), as of today, 
the cellular and molecular mechanisms controlling 
adult tendon repair and remodeling following injury 
are still only poorly understood. Several recent lines 
of evidence in a full-length, central patellar tendon 
healing model using a lineage-tracking strategy have 
revealed that paratenon cells expressing alpha 
smooth muscle actin (αSMA) respond to adult 
patellar tendon injury by turning on Scx to bridge 
the defect (44,45). In the present study, we have 
demonstrated that paratenon cells, a Sca-1-positive 
and Scx-negative progenitor subpopulation, 
differentiate into Scx-expressing tendon cells and act 
as a main player in in tendon repair by migrating to 
the wound site and actively producing ECMs to 
bridge the defect. Progenitor cells in the adult tendon 
are expected to achieve maintenance and repair 
following injury if properly directed towards 
differentiation (14). However, to date, no molecular 
framework exists for understanding the regulatory 
mechanisms by which adult tendon progenitor cells 
differentiate into mature tenocytes. We have 
identified TGF-β-signaling as one of the pathways to 
induce differentiation of adult tendon progenitor 
cells into Scx-expressing tenocytes both in vitro and 
following injury.  
    A recent cell-based tissue-engineering study using 
bone-marrow-derived MSCs transduced with scx 
cDNA has shown that Scx plays a beneficial role in 
repair following adult rat tendon rupture (46). Here 
we provide compelling evidence that the elimination 
of scx results in a deficiency of repair following 
tendon injury due to the lack of ECM assembly in 
paratenon-derived cells to bridge the defect. Recent 
in vitro studies have indicated that transcription of 
the genes pro-alpha2(I) collagen (Col1a2) (47,48) 
and Col1a1 (49) is specifically and directly 
controlled by Scx in tenocytes and cardiac 
fibroblasts. The absence of conversion from collagen 
type III to type I in scx-null wounds following 
tendon injury shown in this study supports the 
hypothesis that the transcriptional control of 
collagen type I is mediated by Scx. Whereas 
transactivation of the Col1a2 promoter is completely 
abrogated by the basic Scx DNA-binding domain-
deleted (Scx∆Base) mutant, the Scx helix-loop-helix 
protein interaction domain-deleted (Scx∆HLH) 
mutant shows a lesser phenotype, suggesting that the 
Scx helix-loop-helix protein interaction is not 
absolutely required for full Scx activity (47,48). 
These observations support our findings showing the 
relation of full-length/mutated scx genes to Sox9 
mRNA regulation during chondrogenesis.  
    The transcription factor Sox9 and TGF-β-
mediated signaling are necessary for chondrogenic 
differentiation in MSCs in vitro (38,50). PGC-1α has 
recently been shown to act as a coactivator for Sox9 
that directly interacts with Sox9 and promotes Sox9-
dependent transcription activity during 
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 8 
chondrogenesis. While Sox9 is expressed not only in 
chondrogenic but also in non-chondrogenic tissues, 
PGC-1α cooperates with Sox9 and they have a 
synergistic effect on the up-regulation of 
chondrogenesis-specific genes such as collagen type 
II α1 chain, followed by TGF-β-induced 
chondrogenesis in MSCs in vitro and developing 
embryo limbs (43). This evidence is consistent with 
our observations demonstrating the significantly 
enhanced chondrogenic potential of scx-null tendon 
progenitor cells with up-regulated Sox9 and PGC-1α 
expression in vitro and the formation of cartilage-
like tissue in scx-null wounds in vivo following 
tendon injury. Our findings suggest that there are 
functional links between Scx and PGC-1α 
expression and the involvement of Scx in negative 
regulation in TGF-β/Sox9-mediated chondrogenesis.  
    The wound in scx-null Achilles tendon following 
partial transection injury results in the spontaneous 
formation of chondroid foci and ectopic ossification. 
An earlier study shows that, upon forced 
overexpression of Sox9 in tenocytes, ectopic 
cartilage formation is preferentially observed in 
dense connective tissues, including 
tendons/ligaments (51). During tooth development, 
over-expression of the scx gene in periodontal 
ligament (PDL) cells results in significant inhibition 
of mineralization by osteo-induction, and 
knockdown of the scx gene results in marked 
upregulation of the osteogenic transcription factor 
osterix, suggesting that Scx counteracts osterix-
driven osteogenesis (52). These findings document 
the counteracting effects of lineage-specific 
transcription factors on cellular differentiation, and 
support the hypothesis that Scx is the key 
transcription factor in the prevention of 
chondrogenesis and osteogenesis. Interestingly, a 
very recent study provides evidence that the absence 
of the tendon-specific transcription factor Mohawk 
causes spontaneous heterotopic ossification of 
Achilles tendon in rats (53).  
    From the current findings, we propose the 
following scenario. Following tendon injury, the 
reduction of physical force from skeletal muscle 
results in the downregulation of Scx or the failure of 
its induction in tendon progenitors. This could cause 
significantly decreased production of ECM to bridge 
the defect, as a result of which these progenitors 
could possess high chondrogenic potential and 
consequently generate chondroid foci and ectopic 
ossification. This phenomenon has biological 
relevance to the slow-healing response to tendon 
injury.  The promotion of increased Scx expression 
levels and the maintenance of Scx-positive cells 
could be promising strategies to improve the slow-
healing response to adult tendon injury. It would be 
of interest to evaluate tendon mechano-properties 
following injury to further address the functional 
role of Scx. The incidence of tendon injury has 
increased in recent years as a result of the aging of 
the population (5,21,54). Heterotopic tendon 
mineralization (ossification or calcification), a 
frequent complication following trauma or surgery, 
is a significant medical problem because it is 
associated with pain and dysfunction (55). Despite 
all efforts, current treatment modalities in adult 
tendon injury are still not optimal, and alternative 
strategies are needed (56). Since there is a critical 
need for repair strategies in adult tendon injuries that 
provide adequate enhancement of patients' healing 
potential, the present study could provide a 
foundational paradigm for evaluating a number of 
modified or alternative therapeutic approaches to 
enhance the tendon environment for healing using 
tendon progenitors.   
 
 
 
Materials and Methods 
 
Mice 
To visualize tenocytes in vivo, ScxGFP transgenic 
mice were used. The ScxGFP transgene features 
tendon-specific regulatory sequences from the 
mouse scx gene that drive the expression of GFP. 
Like the endogenous scx gene, this transgene 
specifically marks tenogenic cells and tenocytes (9). 
To generate mice with a tissue-specific deletion of 
the scx gene, floxed-scx mice were used (10). 
Homozygous floxed-scx mice displayed no obvious 
abnormalities, were fertile, and had a normal 
lifespan. Tomato-red transgenic mice and ROSA26 
(41) mice were from The Jackson Laboratory.  
    All animal experiments were approved by the 
Institutional Animal Care and Use Committee 
(IACUC), and by local ethical review committee and 
licensed by the UK Home Office (70/9039: T. 
Sakai). All mice were maintained and bred at the 
animal facility in accordance with institutional 
guidelines. Mice were regularly monitored and had 
free access to standard mouse chow and water. At 
least 5 mice were used per group in each time point 
and evaluated phenotypes. 
 
Antibodies and reagents 
The following antibodies were used: rabbit 
polyclonal antibodies against mouse Scx (12), 
collagen type I (Chemicon), collagen type II 
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(Chemicon), bovine N-propeptide of collagen type 
III (23), aggrecan (Chemicon); goat polyclonal 
antibody against fibrinogen (Nordic Immunological 
Laboratories), rat monoclonal antibodies against 
Sca-1 (BD Pharmingen), platelet endothelial cell 
adhesion molecule-1 (PECAM-1; BD Pharmingen), 
CD18 (BD Pharmingen), mouse integrin β1 (clone 
9EG7), which recognizes the ligand-inducible 
activated integrin β1 (57) (BD Pharmingen); rabbit 
polyclonal antibody against phospho-Smad2C, 
which specifically recognizes the phosphorylated C-
terminal serine 465/467 of Smad2 (a kind gift from 
Dr Koichi Matsuzaki, Kansai Medical University, 
Japan); rabbit polyclonal antibodies against tyrosine 
397-phosphorylated FAK (BioSouorce), PGC-1α 
(Santa Cruz); rabbit monoclonal antibody against 
Ki67 (Lab Vison); mouse monoclonal antibodies 
against Flag M2 (Sigma), β-actin (clone AC15; 
Sigma), heat shock protein 70 (HSP70; Santa Cruz); 
and Cy3-conjugated donkey anti-rabbit and anti-rat 
IgG, and peroxidase-conjugated donkey anti-mouse 
and anti-rabbit IgG (Jackson ImmunoResearch 
Laboratories). Alexa Fluor 568 donkey anti-goat IgG 
was from Invitrogen. Rabbit polyclonal antibodies 
against fibromodulin and cartilage oligomeric matrix 
protein (COMP) were the kind gift of Dr. Dick 
Heinegård (Lund University, Sweden). The 
following cytokines/growth factors were used: 
recombinant human TGF-β1, -β2 and -β3; 
recombinant mouse GDF5, 7 and 8; recombinant 
human BMP2; recombinant mouse VEGF; 
recombinant human FGF4; recombinant mouse IGF-
1; and porcine PDGF (all from R&D Systems). An 
adenovirus encoding Cre recombinase was a kind 
gift of Dr. Dusko Illic (University of California at 
San Francisco, USA). 
 
Adult mouse Achilles tendon ‘partial-transection’ 
model 
We developed a simple and reproducible ‘partial-
transection’ model to minimize postoperative 
complications. Mice (10–12 weeks old) were 
anesthetized, and the Achilles tendon was exposed 
through an anterolateral skin incision (~1 cm long) 
slightly above the calcaneus. Then a partial 
transection (0.3 mm in width) at ~2 mm proximal 
from the calcaneal insertion was created in the right 
Achilles tendon without massive bleeding using a 
#11 surgical blade (Feather Safety Razor Co.; Fig. 
1B). As an internal control, sham operations were 
performed on the left Achilles tendon. Then the skin 
was closed using 7-0 Ethilon sutures (Ethicon). All 
surgical procedures were performed by a single 
surgeon to enhance consistency. Mice were allowed 
to resume normal cage activity until sacrifice.   
 
Local injection of adenovirus-Cre into wounded 
site of adult Achilles tendon 
To inactivate the scx gene in an injured tendon, we 
used an adenovirus encoding Cre recombinase as 
described previously (12). To determine the most 
appropriate amount of virus for Cre transduction and 
successful excision of the scx-floxed gene in our 
hands in vivo, initial studies were performed using 
mice harboring the well characterized ROSA26 
floxed-LacZ gene. This gene expresses a bifunctional 
lacZ/neomycin phosphotransferase protein in any 
cell (and cell progeny) once recombined by Cre (41). 
We performed single injections of adenovirus-
CreGFP (1 x 108, 5 x 108, and 1 x 109 multiplicity of 
infection [MOI] in 10 µL PBS) into the right 
Achilles tendon of 10-12-week-old Rosa26floxed-
LacZ and wild-type mice. As an internal control, 
PBS alone (10 µL) was injected into the left Achilles 
tendon. We confirmed efficient Cre-mediated gene 
recombination by LacZ staining in tenocytes at 1 
week after injection using a dose of 1 x 109 MOI of 
adenovirus-Cre per mouse (Supplementary Fig. 9A). 
No endogenous LacZ expression was found in wild-
type mice (data not shown).  
    We also gave a single injection of 1 x 109 MOI 
adenovirus-Cre into the Achilles tendon of 10–12-
week-old scx(flox/flox) mice. Considerably 
decreased expression of Scx protein in tenocytes was 
observed by immunohistochemistry at 7 days after 
injection (Supplementary Fig. 9B), indicating that 
adenovirus-Cre at of 1 x 109 MOI results in the 
efficient deletion of floxed alleles in the scx gene. 
No decrease in tenocyte numbers was observed in 
adenovirus-GFP injected control tendons (data not 
shown). 
 
Bone marrow transplantation analysis 
To study the contribution of bone marrow-derived 
cells to tendon wound healing, bone marrow 
transplantation was performed to introduce tomato 
red-labeled bone marrow cells into wild-type mice. 
Adult C57B6 mice (10–12 weeks of age) were 
irradiated at a controlled, sublethal dose of 10 Gy 
(1000 rads), using a gamma irradiator (137Cs-
Shepherd Irradiator). The mice were then 
anesthetized and 2 x 106 bone marrow cells isolated 
from tomato red-transgenic mice were injected into 
recipient mice from the retroorbital venous sinus. 
The recipient mice were kept for a further six weeks 
and were then used for the analysis of Achilles 
tendon injury.  
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Isolation, generation, and characterization of 
mouse adult parental and scx-null tendon 
progenitor cell lines 
We generated parental and scx-null progenitor cell 
lines from adult mouse Achilles tendon. Briefly, 
primary tenocytes from adult scx(flox/flox)/ScxGFP 
mouse Achilles tendon under p53- and p21-null 
genetic background were isolated as described 
previously (11). Since CD90.2 is known to be 
expressed in tendon stem/progenitor cells but not in 
bone marrow stromal cells (14), we next performed  
fluorescence activated cell sorting (FACS) using 
anti-CD90.2 and subsequent stem cell antigen-1 
(Sca-1) antibodies. Then positive cells were cloned 
and several immortalized clones were generated. 
Several of the clones were treated with a Cre-
transducing adenovirus to delete the floxed scx genes 
(12) and the deletion of scx alleles was confirmed by 
PCR (Supplementary Fig. 7A). Both parental scx-
floxed and scx-null progenitor lines showed similar 
fibroblastic morphology (Supplementary Fig. 7B). 
 
Self-renewal and cell differentiation analyses, and 
effects of cytokines/growth factors on ScxGFP 
induction in progenitor cells 
To explore the clonogenic potential of established 
progenitor cell lines, colony-forming unit (CFU) 
assay was performed. Briefly, cells were seeded in 
10-cm Petri dishes at a density of 10 cells/cm2. After 
10 days, colonies formed were visualized by staining 
with 0.5% crystal violet. CFU efficiency was 
calculated with the following formula: CFU [%] = 
(number of colonies formed/number of cells plated) 
× 100.  
    Parental and scx-null progenitor cells were 
differentiated into 3 different mesodermal lineages 
as described previously (58), with some 
modifications. To introduce adipogenic 
differentiation, cells were cultured for 21 days in 
DMEM high-glucose medium supplemented with 
10% FBS, 1 μM dexamethasone, 0.2 mM 
indomethacin, 1 mM 3-isobutyl-1-methylxanthine, 
and 0.1 mg/mL insulin (all reagents were from 
Sigma). Then lipid vacuoles were visualized by Oil 
Red O staining by using a standard protocol. To 
introduce chondrogenic differentiation, cells (3 x 
105) were seeded in M-shaped 96-well plates 
(PrimeSurface 96M, Sumitomo Bakelite Co, Japan) 
to form cell aggregates (pellet culture), and cells 
were further cultured for up to 21 days in 
differentiation medium (composed of DMEM high 
glucose, supplemented with 10 μM dexamethasone, 
1 nM sodium-pyruvate (Invitrogen), 50 µg/mL L-
ascorbic acid 2-phosphate (Sigma), 1% insulin, 
transferrin, and sodium selenite mixtures 
(Invitrogen), and 10 ng/mL TGF-β1 (R&D 
Systems)). Then cell pellets were fixed in 4% 
paraformaldehyde in PBS (pH 7.2), embedded in 
OCT compound (Tissue-Tek, Sakura Finetek), then 
cryosections were prepared and stained with 
Toluidine blue and Safranin O. In some experiments, 
protein and total RNA were isolated and used for 
Western and real-time PCR analysis, respectively. 
To induce osteogenic differentiation, cells (4 × 103 
cells/cm2) were seeded in 12-well plates and cultured 
for 10 days in osteogenic medium (DMEM high 
glucose supplemented with 10% FBS, 10 mM β-
glycerophosphate, 100 nM dexamethasone, 
50 μg/mL L-ascorbic acid 2-phosphate, and 200 
ng/mL BMP2 (R&D Systems)). The extent of 
osteogenic differentiation was determined by 
Alizarin Red staining.  
    For quantification of osteogenic areas, images 
were captured with the same gain, offset, magnitude, 
and exposure time. A minimum of four different 
images were randomly selected and their intensities 
quantified using ImageJ software (version 1.48; 
National Institutes of Health) (59). To quantify 
cellular ScxGFP intensity in response to 
cytokines/growth factors in live progenitors, the 
mean intensity in each cell was measured, and the 
average GFP intensity per cell (fluorescent units) 
was calculated as described previously (11).  
 
Generation of Scleraxis-null and Scleraxis-
expressing tenocyte lines 
Isolation of tenocytes from the Achilles tendon of 
adult mice on a scx(flox/flox)/ScxGFP/p53- and 
scx(flox/flox)/ScxGFP/p21-null genetic background 
was performed as described (11).  Then scx-null and 
its parental cell lines, and full-length Scx and N-
terminal Flag-tag fusion protein-overexpressing 
tendon lines were established as described 
previously (12). To generate murine tenocyte lines 
expressing mutated Scx (Scx with the basic DNA-
binding domain deleted [Scx∆Base] and Scx with 
the helix-loop-helix protein interaction domain 
deleted [Scx∆HLH]), we generated a Scx and Flag-
tag fusion protein expression construct. Flag-tag was 
inserted at the N-terminal end (upstream of the start 
codon) or the C-terminal end (upstream of the stop 
codon) of cDNA encoding scx and cloned in 
lentiviral pCDH-CMV-MCS1-Puro expression 
vector (pCDH-CMV-MCS-Puro_ScxFlag, pCDH-
CMV-MCS-Puro_Scx∆Base, and pCDH-CMV-
MCS-Puro_Scx∆HLH; System Biosciences). For 
lentivirus production, HEK293T cells were 
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transfected with pCMV-VSV-G (Addgene plasmid 
8454), pCMV-dR8.2 dvpr (Addgene plasmid 8455), 
and pCDH-CMV-MCSPuro_full-length 
ScxFlag/mutated ScxFlag or pCDH-CMV-MCS-
Puro (mock) using lipofectamine (Invitrogen) (60). 
Then lentiviral infection was performed in scx-null 
tendon cell lines. To generate stable clones, selection 
with 10 µg/mL puromycin was started at 72 hr after 
transfection, and the surviving clones were isolated 
and expanded. 
 
Histological analysis, immunohistochemistry, and 
immunofluorescence  
To visualize the ScxGFP signal, Achilles tendons 
were fixed in 4% paraformaldehyde/PBS, 
cryoprotected in PBS containing 15% sucrose, and 
frozen in OCT compound (Tissue-Tek, Sakura). 
Cryosections (10-μm thick) were prepared, mounted 
in Vectachield mounting medium containing 4’,6-
diamidino-2-phenylinodole (DAPI; Vector 
Laboratories) and analyzed by fluorescence 
microscopy. After fluorescence analysis, each 
section was stained with hematoxylin and eosin 
(HE) and observed under bright-field illumination as 
described previously (11). Histological analysis, 
lacZ staining, and immunohistochemistry and 
immunofluorescence studies were performed as 
described previously (61,62). 
 
Real-time PCR 
Real-time PCR was performed as described 
elsewhere (11,63). The following primers were used: 
scx forward, 5’-GAGACGGCGGCGAGAAC-3’; 
scx reverse, 5’-
TTGCTCAACTTTCTCTGGTTGCT-3’; sox9 
forward, 5’-CGGCTCCAGCAAGAACAAG-
3’;sox9 reverse, 5’-TGCGCCCACACCATGA-3’;  
collagen type II forward, 5’-
AGAACAGCATCGCCTACCTG-3’; collagen type 
II reverse, 5’-CTTGCCCCACTTACCAGTGT-3’; 
runx2 forward, 5’-
GCCACTTACCACAGAGCTATT-3’; runx2 
reverse, 5’-GAGGCGATCAGAGAACAAACT-3’; 
fibromodulin forward, 5’-
AGCAGTCCACCTACTACGACC-3’; fibromodulin 
reverse, 5’-CAGTCGCATTCTTGGGGACA-3’; 18s 
rRNA forward, 5’-GGCGACGACCCATTCG-3’; 
18s rRNA reverse, 5’-
ACCCGTGGTCACCATGGTA-3’. All samples 
were analyzed at least in triplicate. After the 
reactions, the specificity of amplification in each 
sample was confirmed by dissociation analysis, 
showing that each sample gave a single melting 
peak. Relative mRNA levels were normalized to the 
level of 18S rRNA. 
 
Western blot analysis 
Western blot analyses were performed as described 
elsewhere (23,62). In some immunoblotting analyses, 
samples were transferred onto an Immobilon-FL 
polyvinylidene fluoride (PVDF) membrane 
(Millipore Corp.) and probed with primary and 
IRDye 800CW- or IRDye 680- conjugated 
secondary antibodies (LI-COR Biosciences). 
Immunoreactive bands were detected using the 
Odyssey Infrared Imaging System (LI-COR 
Biosciences). 
 
Micro-CT analysis 
The eXplore Locus micro-CT (GE Healthcare, 
Piscataway, NJ), a gantry-based scanner with a 
rotating X-ray source and detector (fixed anode with 
tungsten target source, operating from 40-80 kVp at 
0.5 mA max current), was used for the analysis. Live 
mice were placed on a linearly encoded, computer-
controlled heated bed that translated (250 mm travel) 
into the gantry. With a rotational precision of 0.05-
degrees, up to 1000 projections were collected in 
step-and-shoot mode using a 16-bit CCD camera 
(1K x 1K)  and one of three resolution modes: 26 μm 
(40 mm-diameter field-of-view), 45 μm (88 mm-
diameter field-of-view), and 93 μm (88 mm-
diameter field-of-view). During acquisition, 
continuous-flow isoflurane anesthesia was 
administered via a nose-cone adapter (Summit 
Anesthesia) and the physiological state of the animal 
(heart rate, temperature, respiration) was monitored 
via electrodes and strain gauges (Spin Systems). For 
situations in which the scanning area was adversely 
affected by breathing-induced motion artifacts, 
acquisition was directly gated using respiratory 
signals.  Following acquisition, reconstruction of 
projection data was performed on a 4PC Unix 
Cluster using a multi-threaded reconstruction 
algorithm.  
 
Data presentation and statistical analysis 
All experiments were performed at least in triplicate 
on separate occasions, and the data shown were 
chosen as representative of results consistently 
observed. Results are presented as means ± standard 
deviation (S.D.). Differences between groups were 
analyzed using the two-sided Student’s t-test on raw 
data. In cases where more than two groups were 
compared, Dunnett’s post hoc test was used. A P 
value of <0.05 was considered significant. 
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Figure Legends 
 
Fig. 1. Adult tendon wound healing after the partial transection in ScxGFP mouse Achilles tendons. 
(A) Partial transection of Achilles tendon. (Left panel) A normal Achilles tendon (Ac) in 10-week-old ScxGFP 
transgenic mice expresses a robust ScxGFP signal (green) under fluorescence stereomicroscopy. (Right panel) 
Partial transection of adult mouse Achilles tendon (Ac) during the operation. Scale bar = 1 mm.  
(B) Analysis of cell death at 3 hr after partial transection at lower (left panel) and higher (right panel) 
magnification: Triple staining for TUNEL (red), ScxGFP (green), and DAPI (cell nuclei; blue). Asterisks indicate 
wounds. Scale bar = 100 µm.  
(C and D) Histological analysis of Achilles tendon in the partial transection model at (C) 3 hr and 2 days after 
injury (in the initial inflammatory stage), and (D) 4 days, and 1, 2, and 4 weeks after injury (in the proliferation 
stage). HE staining (left panels) and the same area with GFP/UV filter (right panels: green, ScxGFP; blue, nuclear 
staining with DAPI). Asterisks in HE sections indicate wounds. An acellular region is formed surrounding the 
wound at day 2 (C; arrowheads). From 1 to 2 weeks after operation, a continuous cellular stream is formed from 
the peri-tendinous region to the wounded site, and these cells start expressing ScxGFP. Scale bar = 100 μm.  
 
Fig. 2. Deposition of ECMs in wound site at 2 weeks (A) and 4 weeks (B) after operation. Collagen type III, type 
I, COMP, or fibromodulin (left panels; red), ScxGFP (middle panels; green), and merged images plus DAPI 
(blue) (right panels). Collagen type III is produced and bridges the wound sites at 2 weeks, and type III fibrils are 
replaced by type I fibrils by 4 weeks. Arrows indicate the wounded area. Scale bar = 100 μm. 
 
Fig. 3. Characterization of cells migrating to the wound site.  
(A) PECAM/DAPI, CD18/DAPI, or Sca-1/DAPI (left panels; PECAM, CD18, and Sca-1 [red]; DAPI [blue], 
ScxGFP/DAPI (middle panels; ScxGFP [green]; DAPI [blue]), and merged images (right panels). The migrating 
cells express tendon progenitor cell marker Sca-1 but are negative for endothelial cell marker PECAM and BMSC 
marker CD18 at 2 weeks after injury. These Sca-1 positive cells show induced ScxGFP expression and 
downregulated Sca-1 expression by 4 weeks after injury. Asterisks indicate the wounded area. Bar = 100 μm. 
(B) Tissue distribution of Sca-1-positive cells in the paratenon-region of adult wound (at 2 weeks after injury; 
upper panels) and untreated (lower panels) Achilles tendon. Triple immunofluorescence staining for Sca-1 
(red)/ScxGFP (green)/DAPI (blue) (left panels), and Ki67 (red)/ScxGFP (green)/DAPI (blue) (right panels). Sca-1 
positive cells localize in the peri-tendinous region in the untreated tendons. Following injury, a notable expansion 
of Sca-1-positive cells is observed with some Ki67 positive cells,Following injury, and migrate into the intra-
tendinous region with the induction of Scx, as evidenced by Sca-1/ScxGFP double positive cells (arrowheads). 
Bar = 50 μm. 
(C) Triple immunofluorescence staining for (from left to right) phospho-Smad-2 (pSmad-2; red), DAPI (blue), 
ScxGFP (green), and merged image in the wounded site of Achilles tendon at 2 weeks after injury. Cells show 
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nuclear expression of pSmad-2 (arrowheads), and some are pSmad2/ScxGFP double positive (asterisks). Scale bar 
= 50 μm. 
 
Fig. 4. Isolation, generation, and characterization of mouse adult parental and scx-null tendon progenitor cell 
lines. 
(A) Expression profiles of cell-surface markers in sorted Scx(fl/fl)/ScxGFP/p21(-/-) cells by FACS analysis.  
(B-E) Characterization of scx-null and its parental adult tendon progenitor cells.  
(B) Self-renewal analysis. (Left panel) Colonies formed visualized by crystal violet at day 10. (Right panel) 
Colony forming unit (CFU) assay in scx-null and its parental progenitor cells. Error bars represent the standard 
deviation (n = 3 for each group). **, P < 0.01.    
(C) Chondrogenic differentiation. (Left panels) Toluidine blue and Safranin O staining at day 21. scx-null 
cultures show cartilage-like tissues. Scale bar = 100 μm. (Right panels) Real-time PCR analysis of Sox9 and 
Type II collagen mRNA levels at day 7 after differentiation. Relative mRNA expression levels are shown relative 
to the control value of 1. Error bars represent the standard deviation (n = 6 for each group). **, P < 0.01.  
(D) Adipogenic differentiation. (Left Panel) Oil red O staining at day 21. scx-null cultures show larger lipid 
droplet-containing adipocytes. Scale bar = 100 μm. (Right panel) Number of adipocytes containing lipid-droplets 
more than 35 µm in diameter. Error bars represent the standard deviation (n = 4 for each group). **, P < 0.01. 
(E) Osteogenic differentiation. (Left Panel) Alizarin red staining at day 21. Scale bar = 500 μm. (Right panel) 
Areas of formation of mineralized and amorphous substances. Error bars represent the standard deviation (n = 4 
for each group). n.s., not significant.  
 
Fig. 5. Tendon wound does not heal without scx. 
(A) HE, and immunofluorescence staining for Sca-1 (red)/DAPI (blue), ScxGFP (green)/DAPI (blue), and merged 
image (from left to right) in scx-Achilles KO mice at 4 weeks following injury. Asterisks in sections indicate 
wounds. Scale bar = 100 μm. 
(B) Deposition of ECMs in wounded site of scx-Achilles KO mice at 4 weeks after injury. Collagen type III, type 
I, COMP, or fibromodulin (left panels; red), ScxGFP (middle panels; green), and merged images plus DAPI 
(blue) (right panels). Collagen type III fibrils are not replaced by collagen type I fibrils at 4 weeks. Arrows 
indicate the wound area. Scale bar = 100 μm. 
 
Fig. 6. Ectopic ossification in the long-term follow up of scx-Achilles KO mice following tendon injury.  
(A-D) Cartilage like tissue formation and ectopic ossification in mutant Achilles tendon following injury.  
(A) Ectopic cartilage-like foci (arrowheads) are formed around the wound site of mutant wounds at 4 weeks 
following injury. Asterisks indicate wounds. Scale bar = 100 μm. 
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(B) Histological analysis of Achilles tendon of mutant mice at 6 weeks following injury. Serial sections stained 
for HE (left panel), aggrecan (red)/DAPI (blue) (middle panel), and collagen type II (red)/DAPI (blue) (right 
panel). Scale bar = 100 μm. 
(C) Histological analysis of Achilles tendon of mutant mice at 8 weeks following injury. (Left panels) HE 
staining (left upper panel) and the same area with GFP/UV filter (left lower panel; green, ScxGFP; blue, DAPI). 
(Right panels) Higher magnification of indicated areas with arrowheads. Scale bars = 100 μm. 
(D) Micro-CT analysis at 15 weeks after injury. Arrow-heads indicate the foci of calcification.  
(E–F) scx-null progenitor cells show significant chondrogenic potential in vitro. 
(E) Western blot analysis of PGC-1α protein expression in scx-null and parental (control) progenitor cells at 24 hr 
after treatment with chondrogenic differentiation medium. The band intensities were measured by densitometry 
and the intensity of the control sample value was set to 1. Each value is shown relative to this control value. The 
positions of molecular weight marker are indicated. 
(F) Real-time PCR analysis of Sox9 mRNA levels at 5 days after treatment with chondrogenic differentiation 
medium in scx(flox/flox) and scx-null tenocytes, and tenocytes overexpressing full-length Scx (scx-full), DNA-
binding domain-deleted Scx (scx∆Base), or helix-loop-helix protein interaction domain-deleted Scx (scx∆HLH). 
Relative mRNA expression level is shown relative to the control value of 1. Error bars represent the standard 
deviation (n = 3 for each group). *, significantly upregulated (P < 0.05); *, significantly downregulated (P < 
0.05); n.s., not significant.  
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